US Stock MarketDetailed Quotes

AOXG Aoxing Pharmaceutical Company, Inc.

Watchlist
  • 0.005100
  • 0.0000000.00%
15min DelayClose Apr 30 16:00 ET
388.67KMarket Cap-510P/E (TTM)

Aoxing Pharmaceutical Company, Inc. Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2017
(Q2)Dec 31, 2016
(Q1)Sep 30, 2016
(FY)Jun 30, 2016
(Q4)Jun 30, 2016
(Q3)Mar 31, 2016
(Q2)Dec 31, 2015
(Q1)Sep 30, 2015
(FY)Jun 30, 2015
(Q4)Jun 30, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-141.19%-3.02M
107.96%87.94K
-65.41%134.94K
-117.68%-534.99K
167.43%1.43M
-170.26%-1.25M
-119.54%-1.11M
117.05%390.15K
139.14%3.03M
-279.62%-2.12M
Net income from continuing operations
-78.78%132.14K
-102.19%-43.45K
-74.33%346.08K
-62.49%2.06M
-145.65%-1.9M
-19.96%622.72K
253.95%1.99M
56,167.90%1.35M
166.88%5.49M
278.21%4.16M
Operating gains losses
-100.11%-26
-100.36%-52
-82.77%4.19K
-6.27%87.5K
-4.78%24.45K
23.35%24.29K
-34.26%14.47K
-6.47%24.29K
-10.85%93.35K
-64.94%25.68K
Depreciation and amortization
-2.96%242.79K
-3.21%252.16K
-8.87%244.54K
53.99%1.03M
267.60%246.95K
-5.97%250.19K
-2.50%260.53K
-4.28%268.35K
-32.71%666.29K
-159.90%-147.34K
Deferred tax
-14.21%196.75K
-243.12%-550.49K
-61.70%339K
123.75%642.25K
68.31%-856.96K
--229.35K
--384.64K
--885.21K
---2.7M
---2.7M
Other non cash items
-102.75%-3.95K
-82.90%36.51K
-59.09%54.08K
-4.55%471.13K
-104.83%-17.94K
85.40%143.34K
406.00%213.53K
4,538.56%132.2K
223.37%493.58K
423.08%371.22K
Change In working capital
-66.37%-4.44M
35.95%-2.5M
59.73%-940.72K
-586.28%-5.53M
186.22%3.38M
-396.19%-2.67M
-182.88%-3.9M
6.39%-2.34M
27.15%-805.37K
-589.74%-3.92M
-Change in receivables
34.96%-1.64M
-960.15%-3.06M
-100.57%-2.93M
-285.61%-6.69M
-494.06%-3.06M
-26.00%-2.53M
163.53%355.64K
-2,872.16%-1.46M
10.18%-1.74M
252.05%776.99K
-Change in inventory
-303.59%-355.38K
139.42%296.84K
462.48%397.61K
114.77%151.21K
166.41%839.28K
1,751.10%174.56K
-292.88%-752.93K
31.35%-109.69K
-332.48%-1.02M
-330.58%-1.26M
-Change in prepaid assets
-7.74%-2.41M
-42.95%-2M
-13.62%-662.83K
103.38%138.77K
233.86%4.36M
-819.24%-2.24M
-450.85%-1.4M
35.43%-583.37K
-5,487.23%-4.1M
-489.79%-3.26M
-Change in payables and accrued expense
-101.30%-25.05K
207.58%2.26M
1,332.98%2.27M
-85.56%874.67K
815.85%1.24M
-25.59%1.92M
-141.04%-2.1M
87.62%-183.86K
1,217.64%6.06M
-122.53%-173.23K
-Change in other working capital
---1.55K
---1.48K
---15.82K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-141.19%-3.02M
107.96%87.94K
-65.41%134.94K
-117.68%-534.99K
167.43%1.43M
-170.26%-1.25M
-119.54%-1.11M
117.05%390.15K
139.14%3.03M
-279.62%-2.12M
Investing cash flow
Cash flow from continuing investing activities
98.65%-80
26.25%-6.64K
97.39%-2.13K
95.64%-117.86K
-107.07%-21.42K
91.58%-5.94K
99.67%-9.01K
53.05%-81.5K
-905.98%-2.71M
414.19%302.86K
Net PPE purchase and sale
98.65%-80
26.25%-6.64K
97.39%-2.13K
95.64%-117.86K
-107.07%-21.42K
91.58%-5.94K
99.67%-9.01K
53.05%-81.5K
-905.98%-2.71M
414.19%302.86K
Cash from discontinued investing activities
Investing cash flow
98.65%-80
26.25%-6.64K
97.39%-2.13K
95.64%-117.86K
-107.07%-21.42K
91.58%-5.94K
99.67%-9.01K
53.05%-81.5K
-905.98%-2.71M
414.19%302.86K
Financing cash flow
Cash flow from continuing financing activities
689.98%3.18M
0
0
10.24%2.95M
-113.35%-320.98K
-76.57%402.94K
97.41%-101.48K
20.06%2.97M
-57.66%2.67M
304.95%2.4M
Net issuance payments of debt
689.99%3.18M
--0
--0
-16.80%207.49K
-123.32%-320.97K
-93.44%402.94K
98.96%-101.48K
-90.81%227K
-96.05%249.38K
131.84%1.38M
Net common stock issuance
----
----
----
13.02%2.74M
--0
--0
--0
--2.74M
--2.42M
--1.03M
Cash from discontinued financing activities
Financing cash flow
689.98%3.18M
--0
--0
10.24%2.95M
-113.35%-320.98K
-76.57%402.94K
97.41%-101.48K
20.06%2.97M
-57.66%2.67M
304.95%2.4M
Net cash flow
Beginning cash position
6.42%6.85M
-13.66%7.06M
28.68%6.91M
130.57%5.37M
26.31%6.05M
380.44%6.44M
248.66%8.17M
130.57%5.37M
-41.87%2.33M
100.24%4.79M
Current changes in cash
119.41%165.77K
106.69%81.29K
-95.94%132.81K
-23.38%2.29M
86.08%1.09M
-124.90%-853.99K
-17.94%-1.22M
35,782.61%3.27M
277.56%2.99M
1,048.02%584.94K
Effect of exchange rate changes
-85.81%66K
44.61%-288.58K
102.33%11.07K
-1,650.82%-753.08K
-98,874.67%-222.69K
2,553.56%464.96K
-2,086.60%-521.03K
-9,518.53%-474.32K
534.44%48.56K
-127.41%-225
End cash Position
17.10%7.08M
6.42%6.85M
-13.66%7.06M
28.68%6.91M
28.68%6.91M
26.31%6.05M
380.44%6.44M
248.66%8.17M
130.57%5.37M
130.57%5.37M
Free cash flow
-140.06%-3.02M
107.30%81.29K
-56.97%132.81K
-303.74%-652.85K
177.47%1.41M
-173.51%-1.26M
-138.53%-1.11M
112.54%308.64K
104.01%320.44K
-177.58%-1.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2017(Q2)Dec 31, 2016(Q1)Sep 30, 2016(FY)Jun 30, 2016(Q4)Jun 30, 2016(Q3)Mar 31, 2016(Q2)Dec 31, 2015(Q1)Sep 30, 2015(FY)Jun 30, 2015(Q4)Jun 30, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -141.19%-3.02M107.96%87.94K-65.41%134.94K-117.68%-534.99K167.43%1.43M-170.26%-1.25M-119.54%-1.11M117.05%390.15K139.14%3.03M-279.62%-2.12M
Net income from continuing operations -78.78%132.14K-102.19%-43.45K-74.33%346.08K-62.49%2.06M-145.65%-1.9M-19.96%622.72K253.95%1.99M56,167.90%1.35M166.88%5.49M278.21%4.16M
Operating gains losses -100.11%-26-100.36%-52-82.77%4.19K-6.27%87.5K-4.78%24.45K23.35%24.29K-34.26%14.47K-6.47%24.29K-10.85%93.35K-64.94%25.68K
Depreciation and amortization -2.96%242.79K-3.21%252.16K-8.87%244.54K53.99%1.03M267.60%246.95K-5.97%250.19K-2.50%260.53K-4.28%268.35K-32.71%666.29K-159.90%-147.34K
Deferred tax -14.21%196.75K-243.12%-550.49K-61.70%339K123.75%642.25K68.31%-856.96K--229.35K--384.64K--885.21K---2.7M---2.7M
Other non cash items -102.75%-3.95K-82.90%36.51K-59.09%54.08K-4.55%471.13K-104.83%-17.94K85.40%143.34K406.00%213.53K4,538.56%132.2K223.37%493.58K423.08%371.22K
Change In working capital -66.37%-4.44M35.95%-2.5M59.73%-940.72K-586.28%-5.53M186.22%3.38M-396.19%-2.67M-182.88%-3.9M6.39%-2.34M27.15%-805.37K-589.74%-3.92M
-Change in receivables 34.96%-1.64M-960.15%-3.06M-100.57%-2.93M-285.61%-6.69M-494.06%-3.06M-26.00%-2.53M163.53%355.64K-2,872.16%-1.46M10.18%-1.74M252.05%776.99K
-Change in inventory -303.59%-355.38K139.42%296.84K462.48%397.61K114.77%151.21K166.41%839.28K1,751.10%174.56K-292.88%-752.93K31.35%-109.69K-332.48%-1.02M-330.58%-1.26M
-Change in prepaid assets -7.74%-2.41M-42.95%-2M-13.62%-662.83K103.38%138.77K233.86%4.36M-819.24%-2.24M-450.85%-1.4M35.43%-583.37K-5,487.23%-4.1M-489.79%-3.26M
-Change in payables and accrued expense -101.30%-25.05K207.58%2.26M1,332.98%2.27M-85.56%874.67K815.85%1.24M-25.59%1.92M-141.04%-2.1M87.62%-183.86K1,217.64%6.06M-122.53%-173.23K
-Change in other working capital ---1.55K---1.48K---15.82K----------------------------
Cash from discontinued investing activities
Operating cash flow -141.19%-3.02M107.96%87.94K-65.41%134.94K-117.68%-534.99K167.43%1.43M-170.26%-1.25M-119.54%-1.11M117.05%390.15K139.14%3.03M-279.62%-2.12M
Investing cash flow
Cash flow from continuing investing activities 98.65%-8026.25%-6.64K97.39%-2.13K95.64%-117.86K-107.07%-21.42K91.58%-5.94K99.67%-9.01K53.05%-81.5K-905.98%-2.71M414.19%302.86K
Net PPE purchase and sale 98.65%-8026.25%-6.64K97.39%-2.13K95.64%-117.86K-107.07%-21.42K91.58%-5.94K99.67%-9.01K53.05%-81.5K-905.98%-2.71M414.19%302.86K
Cash from discontinued investing activities
Investing cash flow 98.65%-8026.25%-6.64K97.39%-2.13K95.64%-117.86K-107.07%-21.42K91.58%-5.94K99.67%-9.01K53.05%-81.5K-905.98%-2.71M414.19%302.86K
Financing cash flow
Cash flow from continuing financing activities 689.98%3.18M0010.24%2.95M-113.35%-320.98K-76.57%402.94K97.41%-101.48K20.06%2.97M-57.66%2.67M304.95%2.4M
Net issuance payments of debt 689.99%3.18M--0--0-16.80%207.49K-123.32%-320.97K-93.44%402.94K98.96%-101.48K-90.81%227K-96.05%249.38K131.84%1.38M
Net common stock issuance ------------13.02%2.74M--0--0--0--2.74M--2.42M--1.03M
Cash from discontinued financing activities
Financing cash flow 689.98%3.18M--0--010.24%2.95M-113.35%-320.98K-76.57%402.94K97.41%-101.48K20.06%2.97M-57.66%2.67M304.95%2.4M
Net cash flow
Beginning cash position 6.42%6.85M-13.66%7.06M28.68%6.91M130.57%5.37M26.31%6.05M380.44%6.44M248.66%8.17M130.57%5.37M-41.87%2.33M100.24%4.79M
Current changes in cash 119.41%165.77K106.69%81.29K-95.94%132.81K-23.38%2.29M86.08%1.09M-124.90%-853.99K-17.94%-1.22M35,782.61%3.27M277.56%2.99M1,048.02%584.94K
Effect of exchange rate changes -85.81%66K44.61%-288.58K102.33%11.07K-1,650.82%-753.08K-98,874.67%-222.69K2,553.56%464.96K-2,086.60%-521.03K-9,518.53%-474.32K534.44%48.56K-127.41%-225
End cash Position 17.10%7.08M6.42%6.85M-13.66%7.06M28.68%6.91M28.68%6.91M26.31%6.05M380.44%6.44M248.66%8.17M130.57%5.37M130.57%5.37M
Free cash flow -140.06%-3.02M107.30%81.29K-56.97%132.81K-303.74%-652.85K177.47%1.41M-173.51%-1.26M-138.53%-1.11M112.54%308.64K104.01%320.44K-177.58%-1.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg